| Sun Pharma Advanced Research Company Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532872 |
NSE Symbol : SPARC |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE232I01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -10.75 |
Market Cap(₹Cr) : 4,960.31 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 7.86 | 9.64 | 27.19 | 14.91 | 12.86 | 16.81 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 7.86 | 9.64 | 27.19 | 14.91 | 12.86 | 16.81 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 9.02 | 0.00 | 0.19 | 0.04 | 1.56 |
| Total Income | 7.87 | 18.66 | 27.19 | 15.10 | 12.90 | 18.37 |
| Total Expenditure | 73.75 | 61.97 | 81.11 | 89.29 | 116.71 | 111.93 |
| PBIDT | -65.88 | -43.31 | -53.92 | -74.19 | -103.81 | -93.56 |
| Interest | 7.52 | 6.18 | 4.51 | 2.77 | 1.11 | 0.52 |
| PBDT | -73.40 | -49.49 | -58.43 | -76.96 | -104.92 | -94.08 |
| Depreciation | 2.57 | 2.54 | 2.55 | 2.75 | 2.77 | 2.76 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -75.97 | -52.03 | -60.98 | -79.71 | -107.69 | -96.84 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -75.97 | -52.03 | -60.98 | -79.71 | -107.69 | -96.84 |
| EPS (Unit Curr.) | -2.34 | -1.60 | -1.88 | -2.46 | -3.32 | -2.98 |
| EPS (Adj) (Unit Curr.) | -2.34 | -1.60 | -1.88 | -2.46 | -3.32 | -2.98 |
| Calculated EPS (Unit Curr.) | -2.34 | -1.60 | -1.88 | -2.46 | -3.32 | -2.98 |
| Calculated EPS (Adj) (Unit Curr.) | -2.34 | -1.60 | -1.88 | -2.46 | -3.32 | -2.98 |
| Calculated EPS (Ann.) (Unit Curr.) | -9.36 | -6.41 | -7.52 | -9.83 | -13.27 | -11.94 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -9.36 | -6.41 | -7.52 | -9.83 | -13.27 | -11.94 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -838.17 | -449.27 | -198.31 | -497.59 | -807.23 | -556.57 |
| PBDTM(%) | -933.84 | -513.38 | -214.90 | -516.16 | -815.86 | -559.67 |
| PATM(%) | -966.54 | -539.73 | -224.27 | -534.61 | -837.40 | -576.09 |